Serina Therapeutics Inc. (SER)
NYSE: SER
· Real-Time Price · USD
5.22
-0.18 (-3.33%)
At close: Aug 18, 2025, 3:54 PM
5.23
0.10%
After-hours: Aug 18, 2025, 06:04 PM EDT
-3.33% (1D)
| Bid | 5.2 |
| Market Cap | 53.56M |
| Revenue (ttm) | 65K |
| Net Income (ttm) | -939K |
| EPS (ttm) | -0.92 |
| PE Ratio (ttm) | -5.68 |
| Forward PE | -3.31 |
| Analyst | Buy |
| Ask | 5.5 |
| Volume | 3,883 |
| Avg. Volume (20D) | 21,875 |
| Open | 5.30 |
| Previous Close | 5.40 |
| Day's Range | 5.22 - 5.40 |
| 52-Week Range | 3.81 - 10.28 |
| Beta | 0.67 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SER stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+2.91%
Serina Therapeutics shares are trading higher on p...
Unlock content with
Pro Subscription
8 months ago
+19.16%
Serina Therapeutics shares are trading higher. The company reveleaed $10 millionin equity financing with shareholder JuvVentures Limited.
3 weeks ago · seekingalpha.com
Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA BreakthroughSeres Therapeutics's VOWST divestiture injected cash, retired debt, and refocused the company as a clinical‑stage microbiome specialist. Their current lead candidate is SER‑155, which seems to reduce ...